Arrowstreet Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4M Buy
506,191
+412,571
+441% +$27.1M 0.01% 709
2026
Q1
$6.66M Buy
+93,620
New +$7.38M ﹤0.01% 1069
2025
Q4
– Sell
-77,529
Closed -$5.82M – 1904
2025
Q3
$5.82M Buy
+77,529
New +$5.78M ﹤0.01% 1124
2025
Q2
– Sell
-28,347
Closed -$2.29M – 1975
2025
Q1
$2.29M Buy
+28,347
New +$2.44M ﹤0.01% 1257
2023
Q4
– Sell
-485,681
Closed -$33M – 1458
2023
Q3
$33M Sell
485,681
-171,982
-26% -$12.5M 0.04% 301
2023
Q2
$53.4M Buy
657,663
+283,514
+76% +$22.6M 0.06% 234
2023
Q1
$30.7M Buy
+374,149
New +$26.7M 0.04% 339

Other funds holding GEHC

Arrowstreet Capital's GEHC Position: Q2 2026 in Review

Arrowstreet Capital increased its GE HealthCare (GEHC) stake by 441% in Q2 2026, buying an estimated $27.1M and bringing the position to 506,191 shares worth $32.4M. The position accounts for 0.01% of the portfolio, ranked #709.

Arrowstreet Capital first reported a position in GEHC in Q1 2023 and has held it in 7 quarters since. The position peaked at $53.4M in Q2 2023. 1,232 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Arrowstreet Capital held 506,191 shares of GE HealthCare worth $32.4M as of Q2 2026.
  • Arrowstreet Capital bought 412,571 GE HealthCare shares in Q2 2026, an estimated $27.1M.
  • GE HealthCare made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #709 holding.
  • Arrowstreet Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 7 quarters since.
  • Arrowstreet Capital's GE HealthCare position peaked at $53.4M in Q2 2023.
  • 1,232 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.